The kidney, hypertension, and obesity

Hypertension

Volumn 41, Issue 3 II, 2003, Pages 625-633

  Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Angiotensin; Blood pressure; Renal disease; Renin; Sodium excretion; Sympathetic nervous system

Indexed keywords

ADRENERGIC SYSTEM; ARTERIAL PRESSURE; CONFERENCE PAPER; ESSENTIAL HYPERTENSION; GLOMERULOPATHY; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY; KIDNEY CORTEX; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY MEDULLA; KIDNEY PERFUSION; KIDNEY TUBULE ABSORPTION; NATRIURESIS; NEPHRON; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM BALANCE;

BLOOD PRESSURE; FEEDBACK, BIOCHEMICAL; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HORMONES; HUMANS; HYPERTENSION; KIDNEY; MODELS, BIOLOGICAL; NATRIURESIS; OBESITY; RENIN-ANGIOTENSIN SYSTEM; SODIUM; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; WATER-ELECTROLYTE BALANCE;

EID: 0037340168     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000052314.95497.78     Document Type: Conference Paper

References (59)

1. Ruskin A. Classics in Arterial Hypertension. Springfield, Ill: Thomas; 1956.
2. Traube L. Uber den Zusammenhang von Herz und Nieren-krankheiten. Gesammelte Beitrage zur Pathologie und Physiologie, vol 2. Berlin: Hirschwald; 1871:290-353.
3. Bright R. Tabular view of the morbid appearances in 100 cases connected with albuminous urine. With observations. Guy's Hosp Rep. 1836;1:380.
4. Starling EH. The fluids of the body. The Herter lectures. Chicago, Ill: Keever; 1909.
5. Guyton AC. Physiological regulation of arterial pressure. Am J Cardiol. 1961;8:401-407.
6. Borst JGG, Borst-de-Geus A. Hypertension explained by Starting's theory of circulatory homeostasis. Lancet. 1963;1:677-682.
7. Guyton AC, Coleman TG. Quantitative analysis of the pathophysiology of hypertension. Circ Res. 1969;24(suppl I):1-19.
8. Goll F. Ueber den Einfluss des Blutdrucks auf die Harnabsonderung. Z Natural Med NF. 1854;4:78.
9. Selkurt EE, Hall PW, Spencer MP. Effect of graded arterial pressure decrement on renal clearance of creatinine, p-amino hippurate and sodium. Am J Physiol. 1949;159:369-384.
10. Hall JE, Granger JP Hester RL, Coleman TG, Smith MJ Jr, Cross RB. Mechanisms of escape from sodium retention during angiotensin II hypertension. Am J Physiol. 1984;246:F627-F634.
11. Hall JE, Granger JP, Smith MJ Jr, Premen AJ. Role of renal hemodynamics and arterial pressure in aldosterone "escape." Hypertension. 1984;6(suppl 1):1183-1192.
12. Knox FG, Granger JP. Control of sodium excretion: an integrative approach. In: Windhager E, ed. Handbook of Renal Physiology. New York, NY: Oxford University Press; 1992:927-967.
13. Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis: a cause or a consequence of hypertension? Hypertension. 1990;15:547-559.
14. Hall JE, Granger JP, Hester RL, Montani J-P. Mechanisms of sodium balance in hypertension: role of pressure natriuresis. J Hypertens. 1986;6(suppl 4):S57-S65.
15. Hester RL, Granger JP, Williams J, Hall JE. Acute and chronic servocontrol of renal perfusion pressure. Am J Physiol. 1983;232:F455-F460.
16. Hall JE, Mizelle HL, Woods LL, Montani J-P. Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion. J Hypertens. 1988;6:723-731.
17. Hall JE, Montani J-P, Woods LL, Mizelle HL. Renal escape from vasopressin: role of pressure natriuresis. Am J Physiol. 1986;250:F907-F916.
18. Woods LL, Mizelle HL, Hall JE. Control of sodium excretion in NE-ACTH hypertension: role of pressure natriuresis. Ant J Physiol. 1988;255:R894-R900.
19. Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension. Kid Int. 1996;49:S35-S41.
20. Hall JE, Brands MW, Shek EW. Central role of the kidney and abnormal fluid volume control in hypertension. J Hum Hypertens. 1996;10:633-639.
21. Mizelle HL, Montani J-P, Hester RL, Didlake RH, Hall JE. Role of pressure natriuresis in long-term control of renal electrolyte excretion. Hypertension. 1993;11:102-110.
22. Hall JE, Guyton AC, Smith MJ Jr, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol. 1980;239:F271-F280.
23. Hall JE. Control of sodium excretion by angiotensin: intrarenal mechanisms and blood pressure regulation. Am J Physiol. 1986;250: R960-R972.
24. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol. 1999;10:S258-S265.
25. Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM. Mechanisms of obesity-associated cardiovascular and renal disease. Am J Med Sci. 2002;324:127-137.
26. Hall JE. Pathophysiology of obesity hypertension. Curr Hypertens Rep. 2000;2:139-147.
27. Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension: role of leptin and sympathetic nervous system. Am J Hypertens. 2001;14:103S-115S.
28. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends on obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
29. Alexander J, Dustan HP, Sims EAH, Tarazi RG. Report of the Hypertension Task Force. US Department of Health, Education, and Welfare Publication 70-1631 (NIH). Washington DC: US Government Printing Office; 1979;61-77.
30. Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP. Body mass index and blood pressures in Korean men and women: the Korean National Blood Pressure Survey. J Hypertens. 1994;12:1433-1437.
31. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16:234-251.
32. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension. 1993;22:292-299.
33. Rocchini AP. The influence of obesity in hypertension. News Physiol Sci. 1990;5:245-249.
34. Carroll JF, Huang M, Hester RL, Cockrell K, Mizelle HL. Hemodynamic alterations in hypertensive obese rabbits. Hypertension. 1995;26:465-470.
35. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 1997;10:S49-S55.
36. Hall JE. Hyperinsulinemia: a link between obesity and hypertension? Kidney Int. 1993;43:1402-1417.
37. Landsberg L, Krieger DR. Obesity, metabolism, and the sympathetic nervous system. Am J Hypertens. 1989;2:1255-1325.
38. Esler M. The sympathetic system and hypertension. Am J Hypertens. 2000;13:99S-105S.
39. Wofford MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of alpha and beta adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens. 2001;14:694-698.
40. Kassab S, Kato T, Wilkins C, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension. 1995;25:893-897.
41. Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL. Sympathetic and cardiorenal actions of leptin. Hypertension. 1997;30:619-623.
42. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:409-414.
43. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin-role of adrenergic activity. Hypertension. 2002;39:496-501.
44. Aizawa-Abe M, Ogawa Y, Mazuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K. Pathophysiological role of leptin in obesity related hypertension. J Clin Invest. 2000;105:1243-1252.
45. Mark AL, Shaffer RA, Correia ML, Morgan DA, Sigmund CD, Haynes WG. Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow mice. J Hypertens. 1999;17:1949-1953.
46. Haynes WG, Morgan DA, Djalal WI, Mark AL. Interaction between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension. 1999;33:542-547.
47. Kuo JJ, Silva PA, Hall JE. Chronic cardiovascular and renal responses to melanocortin-4 receptor activation or inhibition. Hypertension. 2002;40:386.
48. Hall JE, Henegar JR, Shek EW, Brands MW. Role of renin-angiotensin system in obesity hypertension. Circulation. 1997;96:1-33.
49. Robles RG, Villa E, Santirso R, Martinex J, Ruilope LM, Cuesta C, Sancho JM. Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am J Hypertens. 1993;6:1009-1019.
50. Reisen E, Weir M, Falkner B, Hutchinson HG, Anzalone DA, Tuck ML. Lisinoprin versus hydrochlorothiazide in obese hypertensive patients. Hypertension. 1997;30:140-145.
51. Mogensen CE. The reno-protective role of AT(1)-receptor blockers. J Hum Hypertens. 2002;16(suppl 3):S52-S58.
52. Sugerman H, Windsor A, Bessos M, Wolfe L. Intra-abdominal pressure, sagittal abdominal diameter and obesity co-morbidity. J Int Med. 1997;241:71-79.
53. Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Hall JE. Distribution of renal medullary hyaluronan in lean and obese rabbits. Kidney Int. 2000;58:721-729.
54. Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner renal medulla of obese dogs. Hypertension. 1995;25:888-892.
55. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol. 2001;12:1211-1217.
56. Stern JS, Gades MD, Wheeldon CM, Borchers AT. Calorie restriction in obesity: prevention of kidney disease in rodents. J Nutr. 2001;131:913s-917s.
57. U.S. Renal Data System, USRDS. Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001.
58. Wesson DE, Kurtzman NA, Prommer JP. Massive obesity and nephrotic proteinuria with a normal renal biopsy. Nephron. 1985;40:235-237.
59. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity related glomemlopathy: an emerging epidemic. Kidney Int. 2001;59:1498-1509.